サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：脊髄外傷治療の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 治療タイプ別、損傷タイプ別、エンドユーザー別、地域別
市場調査レポート
商品コード
1413742

脊髄外傷治療の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 治療タイプ別、損傷タイプ別、エンドユーザー別、地域別

Spinal Cord Trauma Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)

出版日
ページ情報
英文 183 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円
脊髄外傷治療の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 治療タイプ別、損傷タイプ別、エンドユーザー別、地域別
出版日: 2024年01月11日
発行: Fairfield Market Research
ページ情報: 英文 183 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の脊髄外傷治療の市場規模は、2024年から2031年にかけて大幅な成長を遂げており、この上昇基調を維持すると予測されています。

中東・アフリカの脊髄外傷治療市場の成長に影響を与える課題の1つは、専門治療センターの数が限られていることです。脊髄外傷は主に救急治療室や外傷センターで治療されるが、この地域ではこれらの施設へのアクセスが十分ではないです。適切な治療施設が限られていることが市場の成長を妨げており、アフリカでは救急ヘルスケアへのアクセスが制限されているため、脊髄外傷を患う患者はより高いリスクに直面しています。

外科手術は脊髄損傷治療の現在の標準ですが、障害を治すものではなく、悪化を防ぐだけです。アジア太平洋では、人口のかなりの部分がヘルスケア保険に加入していないため、患者は手術費用を自己負担せざるを得ません。このような手技にかかる高額な費用と限られた効果しかないことが、患者やその家族が外科的治療を選ぶことを躊躇させ、市場成長への課題となっています。

欧州で現在使用されている治療法は、脊髄外傷患者の状態改善に対する治療効果が限られています。そのため、より良い治療を提供し、患者の転帰を改善するための代替治療法の開発への投資が増加しています。幹細胞療法や神経再生療法などの選択肢を模索する調査努力が進められています。こうした治療法の開拓により、効果の低い治療法への依存が減り、従来の外科手術市場の成長が妨げられると予想されます。

当レポートでは、世界の脊髄外傷治療市場について調査し、市場の概要とともに、治療タイプ別、損傷タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナとロシアの紛争の影響
  • 経済概要
  • PESTLE分析

第3章 世界の脊髄外傷治療市場の見通し、2018年～2031年

  • 世界の脊髄外傷治療市場の見通し、治療タイプ別、金額（10億米ドル）、2018年～2031年
  • 世界の脊髄外傷治療市場の見通し、損傷タイプ別、金額（10億米ドル）、2018年～2031年
  • 世界の脊髄外傷治療市場の見通し、エンドユーザー別、金額（10億米ドル）、2018年～2031年
  • 世界の脊髄外傷治療市場の見通し、地域別、金額（10億米ドル）、2018年～2031年

第4章 北米の脊髄外傷治療市場の見通し、2018年～2031年

第5章 欧州の脊髄外傷治療市場の見通し、2018年～2031年

第6章 アジア太平洋の脊髄外傷治療市場の見通し、2018年～2031年

第7章 ラテンアメリカの脊髄外傷治療市場の見通し、2018年～2031年

第8章 中東・アフリカの脊髄外傷治療市場の見通し、2018年～2031年

第9章 競合情勢

  • 治療タイプとエンドユーザーのヒートマップ
  • メーカーとエンドユーザーのヒートマップ
  • 企業の市場シェア分析、2023年
  • 競合ダッシュボード
  • 企業プロファイル
    • Acorda Therapeutics, Inc.
    • Asterias Biotherapeutics
    • ReNetX Bio.
    • BioArctic AB
    • BioTime, Inc.
    • InVivo Therapeutics
    • Kringle Pharma, Inc.
    • Novartis AG
    • Pfizer Inc.
    • Pharmicell Co. Ltd.
    • Vertex Pharmaceuticals Inc.
    • Bioaxone Biosciences, Inc.

第10章 付録

目次

The global market for the treatment of spinal cord trauma has experienced substantial growth from 2024 to 2031, and it is expected to maintain this upward trajectory. A comprehensive research report by Fairfield Market Research also indicates the presence of a significant absolute dollar opportunity, along with an incremental opportunity between 2024 and 2031.

Challenges in the Middle East & Africa

One of the challenges affecting the growth of the spinal cord trauma treatment market in the Middle East & Africa is the limited number of specialized treatment centers. Spinal cord trauma is primarily treated in emergency units and trauma centers, but the region lacks sufficient access to these facilities. Limited availability of proper treatment facilities is hindering the market's growth, and individuals suffering from spinal cord trauma in Africa face higher risks due to restricted access to emergency healthcare.

Cost Barriers in the Asia-Pacific Region

Surgical procedures are the current standard for treating spinal cord injuries, but they do not cure the disorder; they only prevent its worsening. In the Asia-Pacific region, a significant portion of the population lacks healthcare insurance coverage, forcing patients to bear the cost of procedures themselves. The high expense of these procedures and their limited effectiveness are discouraging patients and their families from opting for surgical treatment, posing a challenge to market growth.

Rising Focus on Alternative Treatments in Europe

The treatment modalities currently used in Europe have limited therapeutic impact on improving the condition of patients with spinal cord trauma. Consequently, there is increasing investment in the development of alternative treatment modalities to provide better care and enhance patient outcomes. Research efforts are underway to explore options such as stem cell therapy and nerve regeneration therapy. The development of these therapies is expected to reduce the reliance on less effective treatment methods, thus hampering the growth of the traditional surgery market.

Ineffectiveness of Surgery in Latin America

In Latin American countries, financial considerations play a significant role in determining the preferred treatment approach for spinal cord trauma. Given that surgical procedures cannot completely cure the condition but only prevent its worsening, patients and their families may opt for alternatives when surgery is deemed ineffective. This ineffectiveness of spinal surgery in delivering the required cure is a factor limiting market growth in the region.

Availability of Alternative Treatments in North America

The most preferred treatments for spinal cord trauma in North America involve corticosteroids, spinal traction, and decompression surgical procedures. However, these procedures cannot reverse the damage to the spinal cord. To address this, various biopharmaceutical and medical devices companies in North America are developing alternative treatment options aimed at improving sensory function and treating damaged nerves. The availability of these alternative treatment modalities is expected to restrain the growth of the traditional spinal cord trauma treatment market.

Market Segmentation

By Treatment Type

  • Corticosteroid
  • Surgery
  • Spinal Traction

By Injury Type

  • Complete Spinal Cord Injuries
  • Partial Spinal Cord Injuries

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

By End User

  • Hospitals
  • Trauma Centers

Table of Contents

1. Executive Summary

  • 1.1. Global Spinal Cord Trauma Treatment Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Spinal Cord Trauma Treatment Market Outlook, 2018 - 2031

  • 3.1. Global Spinal Cord Trauma Treatment Market Outlook, by Treatment Type, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Corticosteroid
      • 3.1.1.2. Surgery
      • 3.1.1.3. Spinal Traction
  • 3.2. Global Spinal Cord Trauma Treatment Market Outlook, by Injury Type, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Complete Spinal Cord Injuries
      • 3.2.1.2. Partial Spinal Cord Injuries
  • 3.3. Global Spinal Cord Trauma Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Hospitals
      • 3.3.1.2. Trauma Centers
  • 3.4. Global Spinal Cord Trauma Treatment Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Spinal Cord Trauma Treatment Market Outlook, 2018 - 2031

  • 4.1. North America Spinal Cord Trauma Treatment Market Outlook, by Treatment Type, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Corticosteroid
      • 4.1.1.2. Surgery
      • 4.1.1.3. Spinal Traction
  • 4.2. North America Spinal Cord Trauma Treatment Market Outlook, by Injury Type, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Complete Spinal Cord Injuries
      • 4.2.1.2. Partial Spinal Cord Injuries
  • 4.3. North America Spinal Cord Trauma Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Trauma Centers
  • 4.4. North America Spinal Cord Trauma Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 4.4.1.2. U.S. Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 4.4.1.3. U.S. Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 4.4.1.4. Canada Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 4.4.1.5. Canada Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 4.4.1.6. Canada Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Spinal Cord Trauma Treatment Market Outlook, 2018 - 2031

  • 5.1. Europe Spinal Cord Trauma Treatment Market Outlook, by Treatment Type, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Corticosteroid
      • 5.1.1.2. Surgery
      • 5.1.1.3. Spinal Traction
  • 5.2. Europe Spinal Cord Trauma Treatment Market Outlook, by Injury Type, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Complete Spinal Cord Injuries
      • 5.2.1.2. Partial Spinal Cord Injuries
  • 5.3. Europe Spinal Cord Trauma Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Trauma Centers
  • 5.4. Europe Spinal Cord Trauma Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.2. Germany Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.3. Germany Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.4. U.K. Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.5. U.K. Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.6. U.K. Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.7. France Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.8. France Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.9. France Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.10. Italy Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.11. Italy Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.12. Italy Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.13. Turkey Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.14. Turkey Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.15. Turkey Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.16. Russia Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.17. Russia Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.18. Russia Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.19. Rest of Europe Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.20. Rest of Europe Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.21. Rest of Europe Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Spinal Cord Trauma Treatment Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Spinal Cord Trauma Treatment Market Outlook, by Treatment Type, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Corticosteroid
      • 6.1.1.2. Surgery
      • 6.1.1.3. Spinal Traction
  • 6.2. Asia Pacific Spinal Cord Trauma Treatment Market Outlook, by Injury Type, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Complete Spinal Cord Injuries
      • 6.2.1.2. Partial Spinal Cord Injuries
  • 6.3. Asia Pacific Spinal Cord Trauma Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Trauma Centers
  • 6.4. Asia Pacific Spinal Cord Trauma Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.2. China Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.3. China Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.4. Japan Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.5. Japan Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.6. Japan Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.7. South Korea Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.8. South Korea Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.9. South Korea Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.10. India Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.11. India Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.12. India Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.13. Southeast Asia Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.14. Southeast Asia Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.15. Southeast Asia Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.16. Rest of Asia Pacific Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.17. Rest of Asia Pacific Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.18. Rest of Asia Pacific Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Spinal Cord Trauma Treatment Market Outlook, 2018 - 2031

  • 7.1. Latin America Spinal Cord Trauma Treatment Market Outlook, by Treatment Type, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Corticosteroid
      • 7.1.1.2. Surgery
      • 7.1.1.3. Spinal Traction
  • 7.2. Latin America Spinal Cord Trauma Treatment Market Outlook, by Injury Type, Value (US$ Bn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Complete Spinal Cord Injuries
      • 7.2.1.2. Partial Spinal Cord Injuries
  • 7.3. Latin America Spinal Cord Trauma Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Trauma Centers
  • 7.4. Latin America Spinal Cord Trauma Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.2. Brazil Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.3. Brazil Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 7.4.1.4. Mexico Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.5. Mexico Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.6. Mexico Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 7.4.1.7. Argentina Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.8. Argentina Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.9. Argentina Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 7.4.1.10. Rest of Latin America Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.11. Rest of Latin America Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.12. Rest of Latin America Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Spinal Cord Trauma Treatment Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Spinal Cord Trauma Treatment Market Outlook, by Treatment Type, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Corticosteroid
      • 8.1.1.2. Surgery
      • 8.1.1.3. Spinal Traction
  • 8.2. Middle East & Africa Spinal Cord Trauma Treatment Market Outlook, by Injury Type, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Complete Spinal Cord Injuries
      • 8.2.1.2. Partial Spinal Cord Injuries
  • 8.3. Middle East & Africa Spinal Cord Trauma Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Trauma Centers
  • 8.4. Middle East & Africa Spinal Cord Trauma Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.2. GCC Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.3. GCC Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 8.4.1.4. South Africa Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.5. South Africa Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.6. South Africa Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 8.4.1.7. Egypt Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.8. Egypt Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.9. Egypt Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 8.4.1.10. Nigeria Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.11. Nigeria Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.12. Nigeria Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 8.4.1.13. Rest of Middle East & Africa Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.14. Rest of Middle East & Africa Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.15. Rest of Middle East & Africa Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Treatment Type vs End User Heatmap
  • 9.2. Manufacturer vs End User Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Acorda Therapeutics, Inc.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Treatment Type Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Asterias Biotherapeutics
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Treatment Type Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. ReNetX Bio.
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Treatment Type Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. BioArctic AB
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Treatment Type Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. BioTime, Inc.
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Treatment Type Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. InVivo Therapeutics
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Treatment Type Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Kringle Pharma, Inc.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Treatment Type Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Novartis AG
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Treatment Type Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. Pfizer Inc.
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Treatment Type Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Pharmicell Co. Ltd.
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Treatment Type Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Vertex Pharmaceuticals Inc.
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Treatment Type Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. Bioaxone Biosciences, Inc.
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Treatment Type Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations